Zurich Cantonal Bank’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Zurich Cantonal Bank’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,755	Closed	-$166K	–	2753
2024 Q1	$166K	Buy	4,755 +1,697	+55%	+$61.9K	﹤0.01%	2154
2023 Q4	$116K	Hold	3,058	–	–	﹤0.01%	2372
2023 Q3	$56.1K	Sell	3,058 -1	-0%	-$21	﹤0.01%	2574
2023 Q2	$79.4K	Hold	3,059	–	–	﹤0.01%	2449
2023 Q1	$57.7K	Sell	3,059 -556	-15%	-$12.9K	﹤0.01%	2549
2022 Q4	$89.1K	Sell	3,615 -89	-2%	-$2.62K	﹤0.01%	2343
2022 Q3	$66K	Buy	3,704 +2,989	+418%	+$53.9K	﹤0.01%	2490
2022 Q2	$8K	Hold	715	–	–	﹤0.01%	2867
2022 Q1	$16K	Buy	+715	New	+$18.3K	﹤0.01%	2692

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Zurich Cantonal Bank's INBX Position: Q2 2024 in Review

Zurich Cantonal Bank sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 4,755 shares — an estimated $166K sold.

Zurich Cantonal Bank first reported a position in INBX in Q1 2022 and held it in 9 quarters. The position peaked at $166K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Zurich Cantonal Bank reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Zurich Cantonal Bank sold 4,755 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $166K.
Zurich Cantonal Bank first reported a position in Inhibrx, Inc. Common Stock in Q1 2022 and held it in 9 quarters.
Zurich Cantonal Bank's Inhibrx, Inc. Common Stock position peaked at $166K in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.